Kiltz Uta, Baraliakos Xenofon, Regel Andrea, Bühring Bjoern, Braun Juergen
Rheumazentrum Ruhrgebiet, Herne, Germany.
Clin Exp Rheumatol. 2017 Sep-Oct;35 Suppl 107(5):102-107. Epub 2017 Sep 29.
Back pain, most frequently of the inflammatory type, is the leading symptom in patients with axial spondyloarthritis (axSpA). Back pain in these patients is usually either due to axial inflammation or structural changes based on new bone formation. However, there are other possible causes of pain in these patients. There is, for example, a strongly increased risk of vertebral fractures, and, especially in patients with longstanding disease, degenerative spinal changes may play an additional role as a cause of pain. Rarely, but rather specifically, patients with ankylosing spondylitis may develop subarachnoidal cysts that often cause neurologic symptoms, in extreme cases a cauda equina syndrome. It is therefore mandatory to always carefully evaluate the origin of back pain in these patients and to consider all possible differential diagnoses. The correct diagnosis is of major importance because treatments may differ considerably. In the monitoring of patients with axSpA it is especially important to consider that pain may have a different origin and it is crucial to notice changes in the nature of the reported back pain. Accordingly, the recently updated Assessment of Spondyloarthritis international Society (ASAS)/European League Against Rheumatism (EULAR) and the treat-to-target recommendations both define improvement of symptoms, a reduction of pain and abrogation of inflammation as important targets in axSpA that can be achieved by pharmacological and nonpharmacological treatments, in rare cases including surgical methods.
背痛,最常见的是炎症性背痛,是轴向性脊柱关节炎(axSpA)患者的主要症状。这些患者的背痛通常要么是由于轴向炎症,要么是基于新骨形成的结构变化。然而,这些患者疼痛还有其他可能的原因。例如,椎体骨折的风险大幅增加,而且,尤其是在病程较长的患者中,脊柱退变改变可能作为疼痛原因起到额外作用。强直性脊柱炎患者很少但相当特殊地会出现蛛网膜下囊肿,常导致神经症状,在极端情况下会出现马尾综合征。因此,必须始终仔细评估这些患者背痛的根源,并考虑所有可能的鉴别诊断。正确的诊断至关重要,因为治疗方法可能有很大差异。在axSpA患者的监测中,尤其要考虑到疼痛可能有不同的根源,并且注意所报告背痛性质的变化至关重要。相应地,最近更新的国际脊柱关节炎评估协会(ASAS)/欧洲抗风湿病联盟(EULAR)以及达标治疗建议都将症状改善、疼痛减轻和炎症消除定义为axSpA中的重要目标,这些目标可通过药物和非药物治疗实现,在极少数情况下包括手术方法。